NEW YORK ─ GenMark Diagnostics announced after the close of the market on Thursday preliminary third quarter revenues of approximately $42.6 million, which would represent a 104 percent spike compared to $20.9 million reported in Q3 2019.
NEW YORK ─ GenMark Diagnostics announced after the close of the market on Thursday preliminary third quarter revenues of approximately $42.6 million, which would represent a 104 percent spike compared to $20.9 million reported in Q3 2019.
...and receive Daily News bulletins.
Already have a GenomeWeb or 360Dx account?
Login Now.
Don't have a GenomeWeb or 360Dx account?
Register for Free.
Privacy Policy. Terms & Conditions. . Copyright © 2021 GenomeWeb, a business unit of Crain Communications. All Rights Reserved.